| Report ID | 281897 |
| Drug Identification Number | 02366223 |
| Brand name | CLEVIPREX |
| Common or Proper name | Clevidipine |
| Company Name | CHIESI FARMACEUTICI S.P.A. |
| Market Status | MARKETED |
| Active Ingredient(s) | CLEVIDIPINE |
| Strength(s) | 0.5MG |
| Dosage form(s) | EMULSION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1 |
| Anatomical Therapeutical Chemical (ATC) code | C08CA |
| Anatomical Therapeutical Chemical (ATC) description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-04-20 |
| Actual start date | |
| Estimated end date | 2026-05-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-04-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 26/A VIA PALERMO PARMA, -- ITALY 43122 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2026-04-21 | English | Compare |
| v2 | 2026-03-31 | French | Compare |
| v1 | 2026-03-31 | English | Compare |
Showing 1 to 3 of 3